Ioannis Tarnanas | Nature Portfolio Health Community
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Ioannis Tarnanas (@ITarnanas) / Twitter
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Cognitive Health & Digital Biomarker Technologies | Altoida
Loop | Ioannis Tarnanas
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Ioannis Tarnanas presentations | SlideShare
Ιωάννης Ταρνανάς | Cretalive
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Ioannis Tarnanas's Page – iACToR
Interviews - Trinity Development & Alumni - Trinity College Dublin
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Dr. Ioannis Tarnanas, Ph.D. | LinkedIn
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas (@ITarnanas) / Twitter
Ioannis Tarnanas - Worldwebforum
Stream Ioannis Tarnanas: Atlantic Equity for Equity in Brain Health by Atlantic Fellows | Listen online for free on SoundCloud
Κέρκυρα: Πρωτοπόρα εφαρμογή πρόβλεψης Αλτσχάιμερ από βραβευμένους Έλληνες επιστήμονες που διαπρέπουν σε Αμερική σε συνεργασία με το Ιόνιο Πανεπιστήμιο - Έμβολος
TGL2019 - Dr. Ioannis Tarnanas - YouTube
